Literature DB >> 19032923

The skeleton: endocrine regulator of phosphate homeostasis.

Máire E Doyle1, Suzanne M Jan de Beur.   

Abstract

Phosphorus is an essential element in skeletal development, bone mineralization, membrane composition, nucleotide structure, and cellular signaling. Phosphate, the principal form in which phosphorus is found in the body, is regulated by the complex interplay of the hormones parathyroid hormone (PTH), calcitriol (1,25[OH](2) vitamin D(3)), and fibroblast growth factor 23 (FGF23). These collectively govern bone mineralization, absorption of phosphorus by the intestine, and renal tubular reabsorption of phosphate. The skeleton is the major storage pool for phosphate and the principal production site for FGF23, a major phosphate regulatory hormone. Recent advances in understanding the molecular basis of disorders of phosphate metabolism have revealed new phosphate-regulatory hormones and provided insight into how these regulators may interface with previously known phosphate-regulatory pathways. Here we outline the current knowledge about the regulation of normal phosphate homeostasis and present a review of the molecular basis of disorders of phosphate homeostasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19032923     DOI: 10.1007/s11914-008-0024-6

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  50 in total

1.  Bone as a source of FGF23: regulation by phosphate?

Authors:  Michiko Mirams; Bruce G Robinson; Rebecca S Mason; Anne E Nelson
Journal:  Bone       Date:  2004-11       Impact factor: 4.398

2.  Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism.

Authors:  Takashi Shimada; Yuji Yamazaki; Motoo Takahashi; Hisashi Hasegawa; Itaru Urakawa; Takeshi Oshima; Kaori Ono; Makoto Kakitani; Kazuma Tomizuka; Toshiro Fujita; Seiji Fukumoto; Takeyoshi Yamashita
Journal:  Am J Physiol Renal Physiol       Date:  2005-07-05

3.  A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive.

Authors:  Shoji Ichikawa; Kenneth W Lyles; Michael J Econs
Journal:  J Clin Endocrinol Metab       Date:  2005-02-01       Impact factor: 5.958

4.  Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo.

Authors:  Hitoshi Saito; Akira Maeda; Shu-Ichi Ohtomo; Michinori Hirata; Kenichiro Kusano; Shigeaki Kato; Etsuro Ogata; Hiroko Segawa; Ken-Ichi Miyamoto; Naoshi Fukushima
Journal:  J Biol Chem       Date:  2004-11-05       Impact factor: 5.157

5.  Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.

Authors: 
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

6.  Novel GALNT3 mutations causing hyperostosis-hyperphosphatemia syndrome result in low intact fibroblast growth factor 23 concentrations.

Authors:  Shoji Ichikawa; Vincent Guigonis; Erik A Imel; Mélanie Courouble; Sophie Heissat; John D Henley; Andrea H Sorenson; Barbara Petit; Anne Lienhardt; Michael J Econs
Journal:  J Clin Endocrinol Metab       Date:  2007-02-20       Impact factor: 5.958

7.  A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis.

Authors:  Kaori Araya; Seiji Fukumoto; Rebecca Backenroth; Yasuhiro Takeuchi; Kounosuke Nakayama; Nobuaki Ito; Nozomi Yoshii; Yuji Yamazaki; Takeyoshi Yamashita; Justin Silver; Takashi Igarashi; Toshiro Fujita
Journal:  J Clin Endocrinol Metab       Date:  2005-07-19       Impact factor: 5.958

8.  The Dentin matrix protein 1 (Dmp1) is specifically expressed in mineralized, but not soft, tissues during development.

Authors:  J Q Feng; H Huang; Y Lu; L Ye; Y Xie; T W Tsutsui; T Kunieda; T Castranio; G Scott; L B Bonewald; Y Mishina
Journal:  J Dent Res       Date:  2003-10       Impact factor: 6.116

9.  Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis.

Authors:  Orit Topaz; Daniel L Shurman; Reuven Bergman; Margarita Indelman; Paulina Ratajczak; Mordechai Mizrachi; Ziad Khamaysi; Doron Behar; Dan Petronius; Vered Friedman; Israel Zelikovic; Sharon Raimer; Arieh Metzker; Gabriele Richard; Eli Sprecher
Journal:  Nat Genet       Date:  2004-05-09       Impact factor: 38.330

10.  Klotho is a novel beta-glucuronidase capable of hydrolyzing steroid beta-glucuronides.

Authors:  Osamu Tohyama; Akihiro Imura; Akiko Iwano; Jean-Noël Freund; Bernard Henrissat; Toshihiko Fujimori; Yo-ichi Nabeshima
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

View more
  4 in total

Review 1.  Vitamin D metabolism, functions and needs: from science to health claims.

Authors:  S Battault; S J Whiting; S L Peltier; S Sadrin; G Gerber; J M Maixent
Journal:  Eur J Nutr       Date:  2012-08-12       Impact factor: 5.614

2.  Lameness in fattening pigs - Mycoplasma hyosynoviae, osteochondropathy and reduced dietary phosphorus level as three influencing factors: a case report.

Authors:  B Wegner; J Tenhündfeld; J Vogels; M Beumer; J Kamphues; F Hansmann; H Rieger; E Grosse Beilage; I Hennig-Pauka
Journal:  Porcine Health Manag       Date:  2020-12-15

3.  Clinical factors associated with severe hypophosphataemia after kidney transplant.

Authors:  Maximilian R Ralston; Karen S Stevenson; Patrick B Mark; Colin C Geddes
Journal:  BMC Nephrol       Date:  2021-12-09       Impact factor: 2.388

4.  Dietary Phytase and Lactic Acid-Treated CerealGrains Differently Affected Calcium and PhosphorusHomeostasis from Intestinal Uptake to SystemicMetabolism in a Pig Model.

Authors:  Julia Vötterl; Jutamat Klinsoda; Qendrim Zebeli; Isabel Hennig-Pauka; Wolfgang Kandler; Barbara Metzler-Zebeli
Journal:  Nutrients       Date:  2020-05-25       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.